retatrutide trial results Weight Loss Results:Trial Data and FDA Status Retatrutide Helped Adults With Diabetes

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated clinically significant cardiovascular and kidney benefits in individuals with type 2 diabetes (T2D) and cardiovascular benefits in those with obesity and atherosclerotic cardiovascular disease at baseline 6,7

1 2 Dermatologic Surgery

Cearley CN, Wolfe JH (2007)

Brands that meet their needs will lead the next decade in the GLP-1 adjacent wellness space

Back in 2015, she told Redbook, "There are just some people who are born skinny and with a great metabolism that is not me." That may explain why, almost a decade later, she confirmed she'd taken weight loss medication

This is one change that's sure to stick